BIOCAD is one of the largest biotechnological international innovation companies in Russia, combining world-class research centers, modern pharmaceutical and biotechnological production, preclinical and clinical studies that meet international standards.
BIOCAD is the company of a full cycle of creation of medical products from search of a molecule to mass production and marketing support. The drugs are designed to treat the most complex diseases, such as cancer, HIV, hepatitis, multiple sclerosis, etc. The product portfolio currently consists of 45 medicines, more than 10 of which are biological. More than 40 products are at different stages of development.
The company is the only manufacturer of drugs based on monoclonal antibodies in Russia and Eastern Europe.
In BIOCAD employs more than 1,300 people, of which more than 450 scientists and researchers. Offices and representative offices of the company are located in the USA, Brazil, China, India, Vietnam and other countries.